| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 11.6 | 10.4 |
| Gross profit | 7.5 | 6.3 |
| Profit before tax | 0.2 | -0.8 |
| Net income | 0.2 | -0.8 |
| EPS (diluted, $ a share) | $0.00 | $-0.02 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +11.2% |
|---|---|
| Gross margin | 65.2% |
| Operating margin | 1.6% |
10-Q filed with the SEC, NASDAQ: KRMD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Koru Medical Systems, Inc.: key numbers
- Share price
- $3.49Close, Nov 17
- Market cap
- $151M
- Shares outstanding
- 43.38MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Koru Medical Systems, Inc.
All →Koru Medical Systems CTO Eric Schiller Buys $31K of Stock
Eric Schiller, CTO, bought 8,546 shares of Koru Medical Systems, Inc. at $3.63 a share, worth $31K in total on Nov 13, 2026. Shares held after the trade: 13,546 (+170.9%).
- Value
- $31K
- Shares
- 8,546
- Price
- $3.63
- Role
- CTO
- Holding change
- +170.9%
- Trade date
- Nov 13, 2026
Koru Medical Systems Financial Results
KORU Medical Systems reported Q3 2026 net revenues of $11.6 million, an 11% increase year-over-year, and achieved its second consecutive quarter of positive net income. The company revised its full-year 2026 revenue guidance to $48.0-$48.5 million and highlighted growth in domestic core revenues driven by higher pump and consumable volumes.
- Term
- Q3 2026
“Total Revenue of $11.6 million represents another quarter of consistent above-market growth for KORU, driven by our recurring patient base. We also delivered positive net income and adjusted EBITDA for the second consecutive quarter, demonstrating the scalability of our business model.”
Adam Kalbermatten, President and CEO